---
figid: PMC3565781__rsif20120548-g9
figlink: /pmc/articles/PMC3565781/figure/RSIF20120548F9/
number: F9
caption: (a) Angiogenic signalling pathways and (b) proposed mechanism for high-frequency
  EF regulation of angiogenic response. Our results demonstrate that high-frequency
  EF enhances capillary morphogenesis and VEGF release via the MEK–cRaf step in the
  ERK pathway, with a possible involvement of Ca2+—and, to a lesser extent, eNOS-mediated
  MEK activation. The observed pro-angiogenic effects of EF are frequency-sensitive
  and are independent of VEGF binding to VEGFR2 receptor and PI3K signalling. A potential
  mechanism for these effects is that high-frequency EF may directly regulate the
  interaction of MEK protein with its binding partner cRaf (b), consistent with the
  possibility of gigahertz EF penetrating the cell membrane and affecting intracellular
  signalling. Thus, 7.5 GHz EF may enhance interaction between MEK and its binding
  partner (c-Raf or U0126), resulting in an increased complex formation, increased
  phosphorylation of MEK protein and activation of downstream MAPK/ERK pathway, ultimately
  leading to stimulation of angiogenic responses in the absence of U0126, or inhibition
  of angiogenic responses when U0126 is present.
pmcid: PMC3565781
papertitle: Regulation of endothelial MAPK/ERK signalling and capillary morphogenesis
  by low-amplitude electric field.
reftext: Abdul Q. Sheikh, et al. J R Soc Interface. 2013 Jan 6;10(78):20120548.
pmc_ranked_result_index: '11959'
pathway_score: 0.9646676
filename: rsif20120548-g9.jpg
figtitle: Angiogenic signalling pathways and (b) proposed mechanism for high-frequency
  EF regulation of angiogenic response
year: '2013'
organisms:
- Homo sapiens
ndex: 0e515297-dec7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3565781__rsif20120548-g9.html
  '@type': Dataset
  description: (a) Angiogenic signalling pathways and (b) proposed mechanism for high-frequency
    EF regulation of angiogenic response. Our results demonstrate that high-frequency
    EF enhances capillary morphogenesis and VEGF release via the MEK–cRaf step in
    the ERK pathway, with a possible involvement of Ca2+—and, to a lesser extent,
    eNOS-mediated MEK activation. The observed pro-angiogenic effects of EF are frequency-sensitive
    and are independent of VEGF binding to VEGFR2 receptor and PI3K signalling. A
    potential mechanism for these effects is that high-frequency EF may directly regulate
    the interaction of MEK protein with its binding partner cRaf (b), consistent with
    the possibility of gigahertz EF penetrating the cell membrane and affecting intracellular
    signalling. Thus, 7.5 GHz EF may enhance interaction between MEK and its binding
    partner (c-Raf or U0126), resulting in an increased complex formation, increased
    phosphorylation of MEK protein and activation of downstream MAPK/ERK pathway,
    ultimately leading to stimulation of angiogenic responses in the absence of U0126,
    or inhibition of angiogenic responses when U0126 is present.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK3
  - MAPK1
  - MAPK8
  - MAPK13
  - MAPK11
  - NRAS
  - MAPK9
  - PIK3R6
  - MAPK14
  - PRKCE
  - PRKCG
  - MAPK12
  - PRKCQ
  - KDR
  - KRAS
  - NOS3
  - PRKCD
  - PRKCA
  - PRKCI
  - MAPK10
  - PRKCH
  - PRKCZ
  - HRAS
  - RAF1
  - MAP2K1
  - MAP2K2
  - PIK3R3
  - PIK3R5
  - PRKD3
  - PIK3R4
  - PIK3CB
  - PRKCB
  - PIK3CG
  - PIK3CA
  - PIK3CD
  - Cancer
genes:
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: (PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: (PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: (PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: VEGFR2
  symbol: VEGFR2
  source: hgnc_alias_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: (PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: (PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: (PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: (PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: (PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: cRaf
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: (PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: (PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3565781__F9
redirect_from: /figures/PMC3565781__F9
figtype: Figure
---
